We are honored to announce that Translational Gastroenterology and Hepatology (TGH, Figure 1) has passed all the evaluation required by PubMed Centre (PMC) and is officially accepted for inclusion in PubMed/PMC, two important and extensive biomedical digital databases, which means authors publishing in TGH will enjoy maximum exposure of their research. All previously published content on TGH will be searchable within 1–2 months. TGH would like to express sincere appreciation for the enthusiastic and vigorous support and contributions from all board members, guest editors, reviewers, authors, and readers.
Launched quarterly in April 2012, TGH was originally known as Translational Gastrointestinal Cancer (Apr. 2012–Dec. 2015). The journal title changed into TGH from Jan. 2016 as to cover a broader journal scope, including gastroenterology and hepatology; to ensure a quick turnaround on manuscripts from submission to publication and to comply with the development trend of the Internet age and to allow rapid wide-spread of latest research findings among gastroenterologists and hepatologists.
As an open access and peer-reviewed e-journal, TGH has made significant progress since its inaugural. During the past 5 years, 299 articles have been published in TGH (Figure 2). Among them, 102 articles are included in 5 focused issues and 6 special focuses concentrating on hot topics (Table 1). These issues were guest-edited by leading experts in the field to provide their up-to-date researches and comprehensive overview of the specific topic. Considering that focused issue/special focus would make specific information more intuitive to readers, TGH is planning to publish more focused issues/special issues in the future (Table 2).
Together with all board members, guest editors and authors, the editorial team of TGH aims to develop the journal into a respected source of scientific information and a tool for international collaboration. Now being indexed in PubMed/PMC is a tremendously important step for this goal and we looking forward to working with all friends to take the journal to the next level in 2017 and beyond.
TGH’s publisher: AME Publishing Company
AME Publishing Company (www.amegroups.com) is an international publisher of medical books and journals, who now owns more than 30 English-language international journals covering different fields of medicine, including oncology, pulmonology, cardiothoracic disease and urology. Each journal features peer-reviewed original contributions, comprehensive reviews, and editorials, as well as current case reports etc. AME Publishing Company have an integrated publishing system featuring a professional and highly efficient editorial team, to ensure that every part of our work from sending invitation to online publication goes as close-knit as following the assemble line, needless to say the robust electronic dissemination system for all our journals and articles. Currently, AME has 16 sister journals indexed by PubMed [PubMed Central (PMC) or MEDLINE]. Fourteen journals indexed in Web of Science (WOS) [(SCIE or Emerging Sources Citation Index (ESCI)]: specifically, two journals indexed by SCIE: Journal of Thoracic Disease (JTD) and Translational Cancer Research (TCR); 13 journals indexed by ESCI/WOS: Annals of Cardiothoracic Surgery (ACS), Journal of Gastrointestinal Oncology (JGO), Cardiovascular Diagnosis and Therapy (CDT), Translational Andrology and Urology (TAU), Translational Gastroenterology and Hepatology (TGH), HepatoBiliary Surgery and Nutrition (HBSN), Chinese Clinical Oncology (CCO), Annals of Translational Medicine (ATM), Translational Pediatrics (TP), Gland Surgery (GS), Annals of Palliative Medicine (APM), Quantitative Imaging in Medicine and Surgery (QIMS), Translational Lung Cancer Research (TLCR).
Conflicts of Interest: The author has no conflicts of interest to declare.
Cite this article as: TGH Editorial Office. Translational Gastroenterology and Hepatology is now indexed in PubMed/PMC: a tremendous step forward. Transl Gastroenterol Hepatol 2017;2:6.